Related Experiment Videos
Dexamethasone alters TNF-alpha expression in retinopathy
1Department of Pediatrics, Division of Neonatology, Georgetown University Children's Medical Center, Washington, DC 20007 , USA.
Molecular Genetics and Metabolism
|February 13, 2001
Summary
Tumor necrosis factor-alpha (TNF-alpha) increases during oxygen-induced retinopathy in mice. Dexamethasone treatment suppressed this inflammatory mediator, suggesting TNF-alpha as a therapeutic target for retinopathy.
Area of Science:
- Ophthalmology
- Immunology
- Developmental Biology
Background:
- Tumor necrosis factor-alpha (TNF-alpha) is implicated in retinal inflammation and angiogenesis.
- Its expression is influenced by oxygen levels and it is inhibited by dexamethasone.
Purpose of the Study:
- To investigate the role of TNF-alpha in oxygen-induced retinopathy (OIR) in a mouse model.
- To evaluate the effect of dexamethasone on TNF-alpha expression during OIR.
Main Methods:
- Oxygen-induced retinopathy was induced in C57BL6 mice from postnatal day 7 (P7) to P12.
- Dexamethasone was administered during oxygen exposure.
- TNF-alpha expression was quantified using RT-PCR at P7, P12, and P17.
Main Results:
- TNF-alpha expression naturally increases during retinal development and is further elevated during the vasoproliferative phase of OIR (P17).
- Oxygen exposure transiently suppressed TNF-alpha at P12.
- Dexamethasone significantly inhibited TNF-alpha expression at P17 and suppressed baseline levels.
Conclusions:
- TNF-alpha expression is dynamically altered during OIR, increasing significantly during the critical vasoproliferative phase.
- Dexamethasone effectively suppresses TNF-alpha in this model.
- Modulating TNF-alpha represents a potential therapeutic strategy for oxygen-induced retinopathy.